MURRAY HILL, N.J.--(BUSINESS WIRE)--June 6, 2008--C. R. Bard, Inc.
(NYSE: BCR) today announced that it has closed the previously
disclosed acquisition of the outstanding shares of Specialized Health
Products International, Inc. Bard will immediately commence global
marketing of the acquired line of vascular access products, including
winged infusion sets.
C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill,
N.J., is a leading multinational developer, manufacturer and marketer
of innovative, life-enhancing medical technologies in the fields of
vascular, urology, oncology and surgical specialty products.
This press release may contain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995,
which are based on management's current expectations, the accuracy of
which is necessarily subject to risks and uncertainties. These
statements are not historical in nature and use words such as
"anticipate," "estimate," "expect," "project," "intend," "forecast,"
"plan," "believe," and other words of similar meaning in connection
with any discussion of future operating or financial performance. Many
factors may cause actual results to differ materially from anticipated
results including product developments, sales efforts, income tax
matters, the outcomes of contingencies such as legal proceedings, and
other economic, business, competitive and regulatory factors. The
company undertakes no obligation to update its forward-looking
statements. Please refer to the Cautionary Statement Regarding
Forward-Looking Information in our March 31, 2008 Form 10-Q for more
detailed information about these and other factors that may cause
actual results to differ materially from those expressed or implied.
CONTACT: C. R. Bard, Inc.
Eric J. Shick, 908-277-8413
Vice President, Investor Relations
Holly P. Glass, 703-754-2848
Vice President, Government and Public Affairs
SOURCE: C. R. Bard, Inc.